Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 27;55(5):2000990.
doi: 10.1183/13993003.00990-2020. Print 2020 May.

Short-term outcomes of COVID-19 and risk factors for progression

Li Long  1   2 , Xiansheng Zeng  3   2 , Xu Zhang  4   2 , Wei Xiao  4   2 , E Guo  3   2 , Wenzhi Zhan  1 , Xuejiao Yang  3 , Chunyan Li  4 , Caiyun Wu  3 , Tingting Xu  1 , Chen Zhan  1 , Yuehan Chen  1 , Mei Jiang  1 , Nanshan Zhong  1 , Kefang Lai  1
Affiliations
Comment

Short-term outcomes of COVID-19 and risk factors for progression

Li Long et al. Eur Respir J. .

Abstract

With a median (IQR) follow-up time of 24.0 (17.5–30.0) days, progression occurred in 19.6% moderate, 27.8% severe and 66.7% critical COVID-19. Neutrophil-to-lymphocyte ratio ≥2.973, age ≥50 years, male sex and comorbidity were associated with progression. https://bit.ly/3crsJr0

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Li Long has nothing to disclose. Conflict of interest: Xiansheng Zeng has nothing to disclose. Conflict of interest: Xu Zhang has nothing to disclose. Conflict of interest: Wei Xiao has nothing to disclose. Conflict of interest: E. Guo has nothing to disclose. Conflict of interest: Wenzhi Zhan has nothing to disclose. Conflict of interest: Xuejiao Yang has nothing to disclose. Conflict of interest: Chunyan Li has nothing to disclose. Conflict of interest: Caiyun Wu has nothing to disclose. Conflict of interest: Tingting Xu has nothing to disclose. Conflict of interest: Chen Zhan has nothing to disclose. Conflict of interest: Yuehan Chen has nothing to disclose. Conflict of interest: Mei Jiang has nothing to disclose. Conflict of interest: Nanshan Zhong has nothing to disclose. Conflict of interest: Kefang Lai has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Time from hospital admission to progression, categorised by risk factors: a) age <50 years versus ≥50 years; b) neutrophil-to-lymphocyte ratio (NLR) <2.973 versus ≥2.973; c) with comorbidity versus without comorbidity; and d) female versus male.
See this image and copyright information in PMC

Comment on

  • Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
    Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX; China Medical Treatment Expert Group for COVID-19. Guan WJ, et al. Eur Respir J. 2020 May 14;55(5):2000547. doi: 10.1183/13993003.00547-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32217650 Free PMC article.

References

    1. WHO-China Joint Mission. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-... Date last updated: 24 February 2020. Date last accessed: 4 March 2020.
    1. Yang X, Yu Y, Xu J, et al. . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8: 475–481. doi:10.1016/S2213-2600(20)30079-5 - DOI - PMC - PubMed
    1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. doi:10.1016/S0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Chen N, Zhou M, Dong X, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507–513. doi:10.1016/S0140-6736(20)30211-7 - DOI - PMC - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242. doi:10.1001/jama.2020.2648 - DOI - PubMed

LinkOut - more resources